CD34 and colorectal carcinoma: This speculation is supported by a recent study by Akagi et al (2002), who have reported that a significant increase of MVD determined by Mab to CD105 but not Mab to CD34 was observed from low-grade to high-grade dysplasia of colorectal mucosa, and from high-grade dysplasia to colorectal carcinoma.